LCM
PETX

Landscape Capital Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Landscape Capital Management’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-52,557
Closed -$293K – 949
2015
Q4 		$293K Buy
+52,557
New +$347K 0.04% 698

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Landscape Capital Management's PETX Position: Q1 2016 in Review

Landscape Capital Management sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2016, closing a stake of 52,557 shares — an estimated $293K sold.

Landscape Capital Management first reported a position in PETX in Q4 2015 and held it in 1 quarter. The position peaked at $293K in Q4 2015. 95 funds tracked by Wall St. Rank hold PETX as of Q1 2016.

  • Landscape Capital Management reported no remaining Aratana Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • Landscape Capital Management sold 52,557 Aratana Therapeutics, Inc. shares in Q1 2016, an estimated $293K.
  • Landscape Capital Management first reported a position in Aratana Therapeutics, Inc. in Q4 2015 and held it in 1 quarter.
  • Landscape Capital Management's Aratana Therapeutics, Inc. position peaked at $293K in Q4 2015.
  • 95 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2016.

Based on Landscape Capital Management's 13F filing for Q1 2016, filed 11 May 2016.